Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy in bladder cancer: ready for prime time?

J Clin Oncol. 2014 Dec 20;32(36):4168-9. doi: 10.1200/JCO.2014.58.0498. Epub 2014 Nov 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Transitional Cell / chemistry*
  • Carcinoma, Transitional Cell / drug therapy*
  • Cystectomy*
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Male
  • Neoadjuvant Therapy / methods*
  • Protective Agents / therapeutic use*
  • Urinary Bladder Neoplasms / chemistry*
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Biomarkers, Tumor
  • Protective Agents
  • Granulocyte Colony-Stimulating Factor